• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最大 MEN2A 家系的特征归因于 Cys609Ser RET 突变。

Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation.

机构信息

Endocrinology Unit, University of Padua, Padua, Italy.

出版信息

Fam Cancer. 2009;8(4):379-82. doi: 10.1007/s10689-009-9250-z. Epub 2009 May 28.

DOI:10.1007/s10689-009-9250-z
PMID:19475497
Abstract

RET codon 609 point mutations are rare and may predispose to aggressive medullary thyroid carcinoma (MTC). In a kindred with 15 carriers of the Cys609Ser RET mutation we observed no MTC before 17 years of age, no lymph node metastases before 30 years and no distant metastases before 60 years. Two patients developed pheochromocytoma and one had primary hyperparathyroidism as the first sign of the syndrome. In conclusion, at variance from what already known, in this large kindred the Cys609Ser RET mutation predispose to a scarcely aggressive, highly penetrant MTC and a low penetrance of pheochromocytoma and primary hyperparathyroidism.

摘要

RET 密码子 609 点突变罕见,可能导致侵袭性甲状腺髓样癌(MTC)。在一个家族中有 15 名 Cys609Ser RET 突变携带者,我们观察到 17 岁前没有 MTC,30 岁前没有淋巴结转移,60 岁前没有远处转移。两名患者发生嗜铬细胞瘤,一名患者发生甲状旁腺功能亢进症,为该综合征的首发表现。总之,与已知情况不同,在这个大家族中,Cys609Ser RET 突变导致侵袭性低、高外显率的 MTC 和低外显率的嗜铬细胞瘤和甲状旁腺功能亢进症。

相似文献

1
Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation.最大 MEN2A 家系的特征归因于 Cys609Ser RET 突变。
Fam Cancer. 2009;8(4):379-82. doi: 10.1007/s10689-009-9250-z. Epub 2009 May 28.
2
Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.由种系RET Cys634Trp(TGC>TGG)突变引起的2A型多发性内分泌肿瘤的年龄相关肿瘤风险概况及外显率估计
Endocr Relat Cancer. 2008 Dec;15(4):1035-41. doi: 10.1677/ERC-08-0105. Epub 2008 Sep 15.
3
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.种系 RET 突变位于外显子 10 导致的 2A 型多发性内分泌肿瘤的风险概况和外显率估计。
Hum Mutat. 2011 Jan;32(1):51-8. doi: 10.1002/humu.21385.
4
Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.2A 型多发性内分泌肿瘤源于一个大型北美的家族性系谱中第 8 外显子(G533C)的突变。
Thyroid. 2013 Dec;23(12):1547-52. doi: 10.1089/thy.2012.0599. Epub 2013 Jul 25.
5
Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.D631Y RET 突变致多发性内分泌腺瘤 2A 一家系的临床特征
Thyroid. 2017 Oct;27(10):1332-1334. doi: 10.1089/thy.2016.0536. Epub 2017 Sep 5.
6
RET codon 609 mutations: a contribution for better clinical managing.RET 密码子 609 突变:有助于更好的临床管理。
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):33-6. doi: 10.6061/clinics/2012(sup01)07.
7
High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.日本患者种系 RET 密码子 634 突变导致多发性内分泌肿瘤 2 型中嗜铬细胞瘤的高外显率。
Eur J Endocrinol. 2013 Apr 15;168(5):683-7. doi: 10.1530/EJE-12-1106. Print 2013 May.
8
[A comparison of clinical characteristics between 2 pedigrees of multiple endocrine neoplasia type 2A with different RET mutations].两个具有不同RET突变的2A型多发性内分泌腺瘤病家系临床特征比较
Zhonghua Nei Ke Za Zhi. 2018 Feb 1;57(2):134-137. doi: 10.3760/cma.j.issn.0578-1426.2018.02.010.
9
A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.一个患有非典型2A型多发性内分泌肿瘤的葡萄牙家族中,RET基因第8外显子存在一个罕见的错义变异。
Hormones (Athens). 2016 Jul;15(3):435-440. doi: 10.14310/horm.2002.1691.
10
Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.由于独特的C609S RET突变导致的多发性内分泌腺瘤病2A型表现为嗜铬细胞瘤和甲状腺髓样癌的低外显率。
Clin Endocrinol (Oxf). 2005 Dec;63(6):676-82. doi: 10.1111/j.1365-2265.2005.02400.x.

引用本文的文献

1
MEN2: surgical precision in the era of precision medicine.MEN2:精准医学时代的手术精准性。
Endocr Relat Cancer. 2025 Jun 6;32(6). doi: 10.1530/ERC-24-0251. Print 2025 Jun 1.
2
Primary Hyperparathyroidism in MEN2 Syndromes.MEN2综合征中的原发性甲状旁腺功能亢进症。
Recent Results Cancer Res. 2025;223:237-246. doi: 10.1007/978-3-031-80396-3_9.
3
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.美国甲状腺协会修订的甲状腺髓样癌管理指南。

本文引用的文献

1
Familial prevalence and age of RET germline mutations: implications for screening.RET基因种系突变的家族患病率及年龄:对筛查的意义
Clin Endocrinol (Oxf). 2008 Jul;69(1):81-7. doi: 10.1111/j.1365-2265.2007.03153.x. Epub 2008 Jul 1.
2
The risk of medullary thyroid carcinoma in patients with Hirschsprung's disease.患有先天性巨结肠症的患者患甲状腺髓样癌的风险。
Pediatr Surg Int. 2006 Dec;22(12):991-5. doi: 10.1007/s00383-006-1785-6.
3
Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer.
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
4
Prevalence by age and predictors of medullary thyroid cancer in patients with lower risk germline RET proto-oncogene mutations.低风险种系RET原癌基因突变患者的甲状腺髓样癌年龄别患病率及预测因素
Thyroid. 2014 Jul;24(7):1096-106. doi: 10.1089/thy.2013.0620. Epub 2014 Jun 6.
5
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.多发性内分泌腺瘤病 2 型和家族性甲状腺髓样癌:更新。
J Clin Endocrinol Metab. 2013 Aug;98(8):3149-64. doi: 10.1210/jc.2013-1204. Epub 2013 Jun 6.
6
RET codon 609 mutations: a contribution for better clinical managing.RET 密码子 609 突变:有助于更好的临床管理。
Clinics (Sao Paulo). 2012;67 Suppl 1(Suppl 1):33-6. doi: 10.6061/clinics/2012(sup01)07.
匈牙利遗传性甲状腺髓样癌患者的基因型-表型相关性
Wien Klin Wochenschr. 2006 Jul;118(13-14):417-21. doi: 10.1007/s00508-006-0635-9.
4
Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.由于独特的C609S RET突变导致的多发性内分泌腺瘤病2A型表现为嗜铬细胞瘤和甲状腺髓样癌的低外显率。
Clin Endocrinol (Oxf). 2005 Dec;63(6):676-82. doi: 10.1111/j.1365-2265.2005.02400.x.
5
Advances in the management of hereditary medullary thyroid cancer.遗传性甲状腺髓样癌的管理进展
J Intern Med. 2005 Jan;257(1):50-9. doi: 10.1111/j.1365-2796.2004.01423.x.
6
Multiple endocrine neoplasia 2A syndrome: Surgical management.
J Pediatr Surg. 2002 Jun;37(6):897-900. doi: 10.1053/jpsu.2002.32906.
7
Guidelines for diagnosis and therapy of MEN type 1 and type 2.多发性内分泌腺瘤1型和2型的诊断与治疗指南。
J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71. doi: 10.1210/jcem.86.12.8070.
8
Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma.在2B型多发性内分泌腺瘤和家族性甲状腺髓样癌中鉴定出的具有激酶结构域突变的Ret的生物学和生化特性。
Oncogene. 1999 Jul 1;18(26):3919-22. doi: 10.1038/sj.onc.1202742.
9
A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma.在两个患有家族性甲状腺髓样癌的家族中,RET原癌基因第14外显子804密码子处发生了一个从GTG到ATG的新型点突变。
Hum Mutat. 1998;Suppl 1:S167-71. doi: 10.1002/humu.1380110156.
10
Sipple's syndrome: medullary thyroid carcinoma, pheochromocytoma, and parathyroid disease. Studies in a large family. NIH conference.西普尔综合征:甲状腺髓样癌、嗜铬细胞瘤及甲状旁腺疾病。对一个大家族的研究。美国国立卫生研究院会议。
Ann Intern Med. 1973 Apr;78(4):561-79. doi: 10.7326/0003-4819-78-4-561.